Cory Kasimov
Stock Analyst at Evercore ISI
(4.89)
# 296
Out of 5,088 analysts
1020
Total ratings
56.8%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAM Beam Therapeutics | Reiterated: Buy | $45 | $28.78 | +56.36% | 9 | Oct 28, 2026 | |
| MRNA Moderna | Reiterated: Hold | $80 | $214.17 | -62.65% | 50 | Oct 26, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $130 | $87.99 | +47.74% | 33 | Oct 13, 2026 | |
| ETRA Electra Therapeutics | Initiated Coverage: Buy | $36 | $8.98 | +300.89% | 1 | Oct 13, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $34 | $15.77 | +115.60% | 12 | Sep 29, 2026 | |
| BNTC Benitec Biopharma | Reiterated: Buy | $25 | $8.80 | +184.09% | 2 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $65 → $72 | $43.25 | +66.47% | 3 | Sep 15, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $130 | $70.82 | +83.56% | 20 | Sep 14, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $325 | $232.40 | +39.93% | 8 | Aug 31, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $100 | $61.28 | +63.19% | 12 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $320 | $188.72 | +69.56% | 7 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 → $215 | $145.53 | +47.74% | 17 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $18.76 | +113.22% | 8 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $56.00 | +114.29% | 84 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $40.49 | +35.84% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $36.34 | +120.14% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $22 | $11.93 | +84.41% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $9.30 | +168.82% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $535 | $529.69 | +1.00% | 61 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $38.50 | +29.87% | 1 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $875 → $825 | $813.27 | +1.44% | 77 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $2.98 | +403.36% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $28.77 | +91.17% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 → $128 | $17.20 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $84 | $14.17 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $45.25 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $219 → $221 | $244.05 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $20.32 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $11 | $2.63 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $20 | $1.30 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 → $16 | $2.95 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 → $227 | $451.83 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $98 → $86 | $116.87 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $22.53 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $14.11 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $74 | $159.20 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $10.62 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $83.67 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $40.88 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.1284 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.43 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $100 | $1,288.30 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $276.72 | $9.67 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.118 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.13 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.8321 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $10.32 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $68 | $44.90 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $339.30 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $8.37 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.000001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.74 | n/a | 1 | Jun 4, 2013 |
Beam Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $45
Current: $28.78
Upside: +56.36%
Moderna
Oct 26, 2026
Reiterated: Hold
Price Target: $80
Current: $214.17
Upside: -62.65%
BioNTech SE
Oct 13, 2026
Reiterated: Buy
Price Target: $130
Current: $87.99
Upside: +47.74%
Electra Therapeutics
Oct 13, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $8.98
Upside: +300.89%
Summit Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $34
Current: $15.77
Upside: +115.60%
Benitec Biopharma
Sep 15, 2026
Reiterated: Buy
Price Target: $25
Current: $8.80
Upside: +184.09%
Scholar Rock Holding
Sep 15, 2026
Reiterated: Buy
Price Target: $65 → $72
Current: $43.25
Upside: +66.47%
BridgeBio Pharma
Sep 14, 2026
Reiterated: Buy
Price Target: $130
Current: $70.82
Upside: +83.56%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $325
Current: $232.40
Upside: +39.93%
Cytokinetics
Aug 31, 2026
Reiterated: Buy
Price Target: $100
Current: $61.28
Upside: +63.19%
Aug 27, 2026
Reiterated: Buy
Price Target: $230 → $320
Current: $188.72
Upside: +69.56%
Aug 17, 2026
Reiterated: Buy
Price Target: $210 → $215
Current: $145.53
Upside: +47.74%
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $18.76
Upside: +113.22%
Aug 7, 2026
Reiterated: Buy
Price Target: $120
Current: $56.00
Upside: +114.29%
Aug 7, 2026
Reiterated: Buy
Price Target: $55
Current: $40.49
Upside: +35.84%
Aug 7, 2026
Reiterated: Buy
Price Target: $80
Current: $36.34
Upside: +120.14%
Aug 6, 2026
Reiterated: Buy
Price Target: $18 → $22
Current: $11.93
Upside: +84.41%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $9.30
Upside: +168.82%
Aug 4, 2026
Reiterated: Buy
Price Target: $535
Current: $529.69
Upside: +1.00%
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $38.50
Upside: +29.87%
May 18, 2026
Reiterated: Buy
Price Target: $875 → $825
Current: $813.27
Upside: +1.44%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $2.98
Upside: +403.36%
Mar 17, 2026
Reiterated: Buy
Price Target: $55
Current: $28.77
Upside: +91.17%
Jul 29, 2022
Reiterated: Buy
Price Target: $126 → $128
Current: $17.20
Upside: n/a
Jul 28, 2022
Reiterated: Hold
Price Target: $91 → $84
Current: $14.17
Upside: n/a
Jul 27, 2022
Reiterated: Hold
Price Target: $30 → $33
Current: $45.25
Upside: n/a
Jul 20, 2022
Reiterated: Hold
Price Target: $219 → $221
Current: $244.05
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $20.32
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $14 → $11
Current: $2.63
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $24 → $20
Current: $1.30
Upside: n/a
May 4, 2022
Reiterated: Sell
Price Target: $19 → $16
Current: $2.95
Upside: n/a
Apr 28, 2022
Reiterated: Hold
Price Target: $235 → $227
Current: $451.83
Upside: n/a
Feb 9, 2022
Reiterated: Hold
Price Target: $98 → $86
Current: $116.87
Upside: n/a
Nov 19, 2021
Reiterated: Buy
Price Target: $61
Current: $22.53
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $14.11
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $74
Current: $159.20
Upside: n/a
Feb 25, 2021
Reiterated: Sell
Price Target: n/a
Current: $10.62
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $83.67
Upside: n/a
Nov 13, 2019
Reiterated: Buy
Price Target: n/a
Current: $40.88
Upside: n/a
Jun 26, 2018
Reiterated: Sell
Price Target: n/a
Current: $0.1284
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $3.43
Upside: n/a
Apr 11, 2017
Reiterated: Buy
Price Target: $384 → $100
Current: $1,288.30
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $276.72
Current: $9.67
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.118
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $2.13
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $0.8321
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $10.32
Upside: n/a
Jun 8, 2015
Reiterated: Hold
Price Target: $65 → $68
Current: $44.90
Upside: n/a
Jan 13, 2015
Reiterated: Hold
Price Target: n/a
Current: $339.30
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $8.37
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.000001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $50.74
Upside: n/a